- Previous Close
24,150.00 - Open
0.00 - Bid --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 28,000.00 - Volume
0 - Avg. Volume
1,037,205 - Market Cap (intraday)
544.689B - Beta (5Y Monthly) 1.20
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
FutureChem Co.,Ltd produces and sells radiopharmaceuticals in Korea. The company offers PDVUE, a positron emission tomography (PET) radiopharmaceutical diagnostic medicine for Parkinson's disease; Alzavue, a diagnostic medicine for Aalzheimer's disease; and [18F]FDG, a PET radiopharmaceutical for the treatment of cancer. Its products in pipeline include 18F-FC303, a diagnostic PET radiopharmaceuticals for the treatment of prostate cancer; 177Lu-FC705 for the treatment of prostate cancer; 18F-FMT for the treatment of brain tumor; 18F-FC505, for the treatment of atherosclerotic plaque; and 18F-FC211, for the treatment of Alzheimer's disease. FutureChem Co.,Ltd was founded in 1999 and is headquartered in Seoul, South Korea.
www.futurechem.co.kr67
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 220100.KQ
View MorePerformance Overview: 220100.KQ
Trailing total returns as of 10/4/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 220100.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 220100.KQ
View MoreValuation Measures
Market Cap
544.69B
Enterprise Value
524.35B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
36.50
Price/Book (mrq)
9.32
Enterprise Value/Revenue
35.15
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-58.49%
Return on Assets (ttm)
-7.70%
Return on Equity (ttm)
-13.91%
Revenue (ttm)
14.92B
Net Income Avi to Common (ttm)
-8.73B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
23.54B
Total Debt/Equity (mrq)
5.46%
Levered Free Cash Flow (ttm)
-2.28B